Recent upsurge of A(H7N9) cases in China, updated rapid risk assessment
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China. At present, the most immediate threat to EU citizens is to those living or visiting influenza A(H7N9)-affected areas in China concludes the updated rapid risk assessment.
Epidemiological update: Middle East respiratory syndrome coronavirus (MERS-CoV)
Since the last epidemiological update on 15 June 2015, 25 additional cases and seven deaths in previously reported cases have been reported in South Korea. Health authorities in Thailand reported their first MERS-CoV case.
Epidemiological update: Human infection with avian influenza A(H7N9) virus, China
On 4 February 2015, the National Health and Family Planning Commission (NHFPC) of China notified WHO of 83 additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus. Onset dates ranged from 20 December 2014 to 27 January 2015.
Epidemiological update: MERS-CoV case imported to Turkey, 21 October 2014
On 18 October 2014, the Ministry of Health Turkey reported that a Turkish citizen working in Saudi Arabia died on 11 October 2014, ten days after onset of a confirmed MERS-CoV infection.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.
Epidemiological update: A(H7N9) influenza virus, China, 19 December 2013
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) avian influenza virus in patients in eastern China.
Epidemiological update: Suspected polio cases in Syria confirmed by WHO, 30 October 2013
Ten of the 22 acute flaccid paralysis (AFP) cases in the Syrian Arab Republic suspected of being caused by wild poliovirus have been confirmed as wild poliovirus type 1 (WPV1) by the World Health Organization (WHO).
Epidemiological update: Polio in Israel, 14 October 2013
As of 3 October, wild-type poliovirus 1 (WPV1) was still being isolated in wastewater treatment plants across the country with some areas indicating an inconsistent or discontinued detection. However, no new sites in Israel with WPV1 in sewage were detected since the start of the bivalent oral polio vaccine (bOPV) immunisation campaign, according to personal communication from the Ministry of Health in Israel.
Epidemiological update: Polio virus in sewage and human faecal samples in Israel, August 2013
In May 2013, Israel announced the detection of wild poliovirus type 1 (WPV1) in the south of the country (1). As reported until mid-August, during the routine monitoring of sewage samples the virus had been found in 67 sewage samples from 24 sampling sites since February 2013.
Epidemiological update of 29 April on avian influenza A(H7N9) virus
Since 31 March 2013, one hundred and twenty one (121) cases of human infection with avian influenza A(H7N9) virus have been reported from eight provinces and two municipalities in eastern China and one (1) from Taiwan.